Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC
URMC / Research / Clinical Trials / Study Details

Safety and Efficacy of Chlorthalidone in Type 1 Diabetes

Research Question:
Does the drug chlorthalidone reduce the amount of calcium in urine in type 1 diabetics?

Basic Study Information

Chlorthalidone is a prescription drug used to treat high blood pressure (hypertension). This open-label study will determine if chlorthalidone is safe and effective for the use of reducing the amount of calcium in urine over 4 weeks in patients with type 1 diabetes.

Location: University of Rochester

Lead Researcher (Principal Investigator)

Lead Researcher: David Weber

Study Contact Information

Study Coordinator: David Weber

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search